Brown Brothers Harriman & Co’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,952
Closed -$346K 1280
2020
Q1
$346K Sell
1,952
-82
-4% -$15.4K ﹤0.01% 279
2019
Q4
$389K Sell
2,034
-975
-32% -$176K ﹤0.01% 345
2019
Q3
$506K Buy
3,009
+227
+8% +$37K ﹤0.01% 290
2019
Q2
$466K Buy
2,782
+41
+1% +$5.68K ﹤0.01% 281
2019
Q1
$401K Buy
2,741
+873
+47% +$127K ﹤0.01% 286
2018
Q4
$250K Buy
1,868
+47
+3% +$7.71K ﹤0.01% 317
2018
Q3
$347K Buy
1,821
+350
+24% +$64.3K ﹤0.01% 292
2018
Q2
$245K Sell
1,471
-64
-4% -$10.3K ﹤0.01% 316
2018
Q1
$258K Sell
1,535
-73
-5% -$12.2K ﹤0.01% 301
2017
Q4
$263K Buy
1,608
+140
+10% +$25.1K ﹤0.01% 306
2017
Q3
$301K Hold
1,468
﹤0.01% 275
2017
Q2
$357K Hold
1,468
﹤0.01% 260
2017
Q1
$351K Sell
1,468
-236
-14% -$55K ﹤0.01% 262
2016
Q4
$358K Sell
1,704
-5,951
-78% -$1.23M ﹤0.01% 243
2016
Q3
$1.76M Sell
7,655
-3,764
-33% -$920K 0.01% 145
2016
Q2
$2.64M Buy
11,419
+452
+4% +$104K 0.01% 128
2016
Q1
$2.94M Buy
10,967
+854
+8% +$244K 0.02% 124
2015
Q4
$3.16M Sell
10,113
-823
-8% -$245K 0.02% 118
2015
Q3
$2.97M Buy
10,936
+2,354
+27% +$723K 0.02% 121
2015
Q2
$2.6M Sell
8,582
-1
-0% -$298 0.01% 133
2015
Q1
$2.56M Buy
8,583
+8,167
+1,963% +$2.33M 0.01% 130
2014
Q4
$107K Hold
416
﹤0.01% 432
2014
Q3
$100K Buy
416
+16
+4% +$3.58K ﹤0.01% 438
2014
Q2
$88K Hold
400
﹤0.01% 451
2014
Q1
$82K Hold
400
﹤0.01% 438
2013
Q4
$67K Hold
400
﹤0.01% 424
2013
Q3
$58K Hold
400
﹤0.01% 451
2013
Q2
$50K Buy
+400
New +$45.3K ﹤0.01% 535

Other funds holding AGN

Brown Brothers Harriman & Co's AGN Position: Q2 2020 in Review

Brown Brothers Harriman & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,952 shares — an estimated $346K sold.

Brown Brothers Harriman & Co first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $3.16M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Brown Brothers Harriman & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 1,952 Allergan plc shares in Q2 2020, an estimated $346K.
  • Brown Brothers Harriman & Co first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Brown Brothers Harriman & Co's Allergan plc position peaked at $3.16M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2020, filed 13 Aug 2020.